The chronic stress induced expression of DPP-4 and its role in adipose inflammation and glucose metabolism

Expand
  • 1. Department of Emergency and Traumatic Surgery, 2. Research Institute of General and Minimally Invasive Surgery, 3. Department of Minimally Invasive Surgery, Hernia and Abdominal Wall Surgery, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830001, China

Received date: 2019-05-15

  Online published: 2020-07-29

Abstract

Objective To analyze chronic stress induced dipeptidyl peptidase-4 (DPP-4) expression and its role in adipose inflammation and glycometabolism. Methods 20 male SPF mice were randomly divided into two groups: a stress group and a control group. Mice in the stress group were restrained in our own restraint device for 2 hours per day and lasted for 14 days. The expression of macrophage surface marker (CD11b) in adipose tissue was detected by immunohistochemistry. The expression of DPP-4, adipocytokines (Adiponectin, MCP-1, IL-6, TNF-α) in adipose tissue and the expressions of glucose metabolism molecules (IRS-1, GLUT-4) were further detected by RT-PCR. The enzymatic activity of DPP-4 and the concentration of GLP-1 were detected by ELISA. Results The white adipose tissue (WAT) of the stress group mice significantly retracted and WAT weight significantly reduced (P<0.001). WAT in the stress group showed a large number of monocytes, neutrophils infiltration and inflammatory changes. Mice in the stress group significantly decreased the expression of Adiponectin and significantly increased the expression of MCP-1, IL-6 and TNF-α (P<0.001). DPP-4 expression in WAT tissues and its activity in blood increased significantly in the stress group, but the concentration of serum GLP-1 decreased significantly (P<0.001). The mRNA level of IRS-1 and mRNA level of GLUT-4 in WAT of the stress group were significantly lower than that of the control group (P<0.001). Conclusions Chronic stress induced abnormal expression of DPP-4 in adipose tissue, which can lead to adipose inflammation and abnormal glycometabolism.

Cite this article

ABULAIKEMU·Mahemuti, MAIMAITI·Yisireyili, AIKEBAIER·Aili, LI Yi-liang, AZIGULI -Alimujiang, YAN Jing, KELIMU·Abudureyimu . The chronic stress induced expression of DPP-4 and its role in adipose inflammation and glucose metabolism[J]. Chinese Journal of Clinical Anatomy, 2020 , 38(4) : 438 -443 . DOI: 10.13418/j.issn.1001-165x.2020.04.014

References

[1]  Carrier A. Metabolic syndrome and oxidative stress: a complex relat-ionship[J]. Antioxid Redox Signal, 2017, 26 (9):429-431. 
[2]  Liu YZ, Wang YX, Jiang CL. Inflammation: the common pathway of stress-related diseases[J]. Front Hum Neurosci, 2017, 11: 316.
[3] Secrest MH, Udell JA, Filion KB. The cardiovascular safety trials of DPP-4 inhibitors, GLP-1 agonists, and SGLT2 inhibitors[J]. Trends Cardiovasc Med, 2017, 27(3):194-202. 
[4] Dandekar A, Mendez R,  Zhang K. Cross Talk Between ER Stress, Oxidative Stress, and Inflammation in Health and Disease[J]. Methods Mol Biol, 2015,1292(3):205-214. 
[5]  Sharma D, Verma S, Vaidya S, et al. Recent updates on GLP-1 agonists: Current advancements & challenges[J]. Biomed Pharmacother, 2018, 108(88):952-962. 
[6] Yisireyili M, Uchida Y, Yamamoto K, et al. Angiotensin receptor blocker irbesartan reduces stress-induced intestinal inflammation via AT1a signaling and ACE2-dependent mechanism in mice[J]. Brain Behav Immun, 2018, 69 (010):167-179.
[7]  Yisireyili M, Takeshita K, Hayashi M, et al. Dipeptidyl peptidase- IV inhibitor alogliptin improves stress-induced insulin resistance and prothrombotic state in a murine model[J]. Psychoneuroendocrinology, 2016, 73(4):186-195.
[8] Takayanagi R, Uchida T, Kimura K, et al. Evaluation of drug efficacy of GLP-1 receptor agonists and DPP-4 inhibitors based on target molecular binding occupancy[J]. Biol Pharm Bull, 2018, 41(2):153-157. 
[9]  Senyigit A, Tabak O, Orhanoglu T, et al. Glucagon-like peptide-1 levels and dipeptidyl peptidase-4 activity in type 2 diabetes[J]. Clin Invest Med, 2017, 40(5):E188-E199.
[10] 买买提·依斯热依力, 买买提艾力·艾则孜, 吾布力卡斯木·吾拉木,等. 慢性束缚应激诱导脂肪Nox-4表达及其在脂肪炎症发生中的作用[J]. 中华内分泌代谢杂志, 2019, 35(5) : 410-416. 
[11] 胡仁明,谢颖,鹿斌,等. 2型糖尿病患者高发“代谢性炎症综合征”[J]. 中华内分泌代谢杂志,2016,32(1): 27-30.
[12] Burhans MS, Hagman DK, Kuzma JN, et al. Contribution of adipose tissue inflammation to the development of type 2 diabetes mellitus[J]. Compr Physiol, 2018, 9(1):1-58. 
[13] Yahagi K, Kolodgie FD, Lutter C, et al. Pathology of human coronary and carotid artery atherosclerosis and vascular calcification in diabetes mellitus[J]. Arterioscler Thromb Vasc Biol, 2017, 37(2):191-204. 
[14] Kacso T, Bondor CI, Rusu CC, et al. Adiponectin is related to markers of endothelial dysfunction and neoangiogenesis in diabetic patients[J].  Int Urol Nephrol, 2018, 50 (9):1661-1666. 
[15] 买买提·依斯热依力,阿孜古丽·阿力木江,吾布力卡斯木·吾拉木,等.Nox-4在慢性束缚应激致小鼠胃黏膜炎症损伤发生中的作用[J]. 中华行为医学与脑科学杂志, 2019, 28(4):316-321.
[16] Yisireyili M, Hayashi M, Wu H, et al. Xanthine oxidase inhibition by febuxostat attenuates stress-induced hyperuricemia, glucose dysmetabolism, and prothrombotic state in mice[J]. Sci Rep, 2017, 7(1):1266. 
Options
Outlines

/